Tavalisse
My Prescription
Payment
Select pharmacy



$16,478.72
Print or send this coupon to your phone
About Tavalisse
Drug Details
Fostamatinib, marketed under the brand name Tavalisse, is a medication designed to increase platelet counts in adults suffering from chronic immune thrombocytopenia (ITP), a blood disorder characterized by an abnormally low number of platelets, which can lead to severe bleeding issues. This drug is specifically intended for individuals who have not responded adequately to other treatment options. Fostamatinib functions by inhibiting spleen tyrosine kinase, a protein that plays a role in the immune system's destruction of platelets. By blocking this protein, the drug helps to prevent antibody-mediated platelet destruction. It is administered orally, typically twice a day. Patients should be aware of potential side effects, including high blood pressure, infection, and liver complications, and should consult with healthcare professionals to ensure it is a suitable and safe option for their condition.
Price history for Tavalisse
60 Tablets, 100MG
Average retail price for Tavalisse
Average SaveHealth price for Tavalisse
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Tavalisse dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 100MG | 60 Tablets | $16,478.72 | $274.65 |
| 150MG | 60 Tablets | $16,478.72 | $274.65 |
Tavalisse FAQs
Tavalisse is used for the treatment of thrombocytopenia in adults with chronic immune thrombocytopenia (ITP) who have had an insufficient response to previous treatment.
The cost of Tavalisse can vary depending on factors such as the pharmacy, location, insurance coverage, and any available discounts or patient assistance programs. It is recommended to contact a local pharmacy or healthcare provider for the most accurate and up-to-date pricing information. Additionally, patients may inquire about financial assistance programs that could help reduce the cost.
Yes, Tavalisse (fostamatinib) is considered an immunosuppressant. It works by inhibiting certain enzymes that play a role in the immune response, which can help reduce the destruction of platelets in conditions like chronic immune thrombocytopenia (ITP).
The success rate of Tavalisse (fostamatinib) can vary depending on the specific condition being treated and individual patient factors. In clinical trials for chronic immune thrombocytopenia (ITP), Tavalisse demonstrated a significant improvement in platelet counts for many patients. Approximately 18% of patients achieved a stable platelet response compared to 2% in the placebo group. It is important for patients to discuss with their healthcare provider to understand how Tavalisse may work for their specific situation.
An alternative to Tavalisse (fostamatinib) for the treatment of chronic immune thrombocytopenia (ITP) may include other medications such as corticosteroids, intravenous immunoglobulin (IVIG), or thrombopoietin receptor agonists like eltrombopag (Promacta) and romiplostim (Nplate). The choice of treatment should be based on the patient's specific condition and medical history, and it is important to consult with a healthcare provider to determine the most appropriate option.